Patents Assigned to Neuroderm Ltd.
  • Compositions comprising nicotinic agonists and methods of using same
    Patent number: 8273731
    Abstract: The disclosure is directed at least in part to compositions and methods comprising nicotinic agonists for treating e.g., nervous system disorders, in particular, to combination therapies that include a nicotinic agonist (for example, nicotine) and a nicotinic acetylcholine receptor desensitization inhibitor (for example, opipramol).
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: September 25, 2012
    Assignee: Neuroderm Ltd.
    Inventor: Eliahu Heldman
  • Apparatus for the transdermal treatment of Parkinson's disease
    Patent number: 6746688
    Abstract: A pharmaceutical composition for treatment of Parkinson's disease comprising a compound of levodopa dissolved in a non-degradative solvent which allows transdermal administrtion of levodopa. The compound of levodopa is an alkyl-ester of levodopa and the solvent is a formulation comprising a substantially non-aqueous solvent, a transdermal enchancer and a detergent. The alkyl-ester of levodopa is preferably levodopa-ethyl-ester (LDEE).
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: June 8, 2004
    Assignee: Neuroderm Ltd.
    Inventors: Moshe Kushnir, Eliahu Heldman